Fig. 3: Treatment-free remission (TFR) after second tyrosine kinase inhibitor (TKI) discontinuation.
TFR probability at 6, 12 and 24 months was 61, 56 and 46% respectively.
Fig. 3: Treatment-free remission (TFR) after second tyrosine kinase inhibitor (TKI) discontinuation. | Leukemia
